These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31959465)

  • 1. Association of high-sensitivity C-reactive protein with susceptibility to Schizophrenia in Tunisian population.
    Ayari F; Ben Chaaben A; Ben Ammar H; Nefzi R; Ouni N; Mihoub O; Abaza H; Aissa A; Douik H; Gara S; Larnaout A; Salmi A; Ben Ammar-El Gaaied A; Leboyer M; El Hechmi Z; Guemira F; Tamouza R
    Encephale; 2020 Aug; 46(4):241-247. PubMed ID: 31959465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum High-Sensitive C-Reactive Protein Level and CRP Genetic Polymorphisms Are Associated with Abdominal Aortic Aneurysm.
    Shangwei Z; Yingqi W; Jiang X; Zhongyin W; Juan J; Dafang C; Yonghua H; Wei G
    Ann Vasc Surg; 2017 Nov; 45():186-192. PubMed ID: 28549956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
    Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups.
    Joseph J; Depp C; Martin AS; Daly RE; Glorioso DK; Palmer BW; Jeste DV
    Schizophr Res; 2015 Oct; 168(1-2):456-60. PubMed ID: 26341579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [C-reactive protein and agitation in patients with schizophrenia: A cohort study with a control group].
    Kachouchi A; Sebbani M; Akammar S; Berghalout M; Adali I; Manoudi F; Amine M; Asri F
    Encephale; 2020 Aug; 46(4):264-268. PubMed ID: 32057410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort.
    Fond G; Sunhary de Verville PL; Richieri R; Etchecopar-Etchart D; Korchia T; Faugere M; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Leboyer M;
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110335. PubMed ID: 33933539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
    Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
    Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study.
    Metcalf SA; Jones PB; Nordstrom T; Timonen M; Mäki P; Miettunen J; Jääskeläinen E; Järvelin MR; Stochl J; Murray GK; Veijola J; Khandaker GM
    Brain Behav Immun; 2017 Jan; 59():253-259. PubMed ID: 27622678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.
    Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR
    Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
    Quidé Y; Bortolasci CC; Spolding B; Kidnapillai S; Watkeys OJ; Cohen-Woods S; Berk M; Carr VJ; Walder K; Green MJ
    Psychol Med; 2019 Dec; 49(16):2736-2744. PubMed ID: 30560764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses.
    Aas M; Dieset I; Hope S; Hoseth E; Mørch R; Reponen E; Steen NE; Laskemoen JF; Ueland T; Aukrust P; Agartz I; Andreassen OA; Melle I
    Brain Behav Immun; 2017 Oct; 65():342-349. PubMed ID: 28619247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences.
    Lee EE; Ancoli-Israel S; Eyler LT; Tu XM; Palmer BW; Irwin MR; Jeste DV
    Am J Geriatr Psychiatry; 2019 Jan; 27(1):21-31. PubMed ID: 30442531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia.
    Fawzi MH; Fawzi MM; Fawzi MM; Said NS
    Psychiatry Res; 2011 Nov; 190(1):91-7. PubMed ID: 21621854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.
    Bulzacka E; Boyer L; Schürhoff F; Godin O; Berna F; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chéreau-Boudet I; Chesnoy-Servanin G; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Roux P; Yazbek H; Leboyer M; Fond G;
    Schizophr Bull; 2016 Sep; 42(5):1290-302. PubMed ID: 27143795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum high-sensitivity C-reactive protein levels are positively associated with cognitive impairments in patients with first-episode schizophrenia.
    Zhu J; Hu W; Zhou Y; Qiao J; Chang X; Tong Z
    Compr Psychiatry; 2019 Oct; 94():152118. PubMed ID: 31450022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India.
    Gurung J; Chamlagai D; Bera NK; Chaudhuri TK; Singh B
    Nord J Psychiatry; 2018 May; 72(4):311-317. PubMed ID: 29464976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein gene variants: independent association with late-life depression and circulating protein levels.
    Ancelin ML; Farré A; Carrière I; Ritchie K; Chaudieu I; Ryan J
    Transl Psychiatry; 2015 Jan; 5(1):e499. PubMed ID: 25603415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of C-reactive protein in schizophrenia: an overview.
    Singh B; Chaudhuri TK
    Psychiatry Res; 2014 May; 216(2):277-85. PubMed ID: 24565000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.